Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2003
11/06/2003WO2002059108A8 Melanocortin receptor agonists
11/06/2003WO2002058792A8 Rehydration composition
11/06/2003WO2002046475A3 Method of detecting and treating tuberous sclerosis complex associated disorders
11/06/2003WO2002045708A9 Use of zwitterionic polysaccharides for the specific modulation of immune processes
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002034204A3 Calcilytic compounds
11/06/2003WO2002032435A3 A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
11/06/2003WO2002030408A3 Compositions comprising phospholipase c inhibitors and methods for enhancing paracellular permeability across epithelial and endothelial barriers
11/06/2003WO2002030257A3 Normalization of defective t cell responsiveness through manipulation of thymic regeneration
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2002018369A8 Peptidomimetic protease inhibitors
11/06/2003WO2002009639A3 Methods and pharmaceutical compositions for healing wounds
11/06/2003WO2002004952A3 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
11/06/2003WO2002004418A3 Methods of inhibiting uterotrophic effects of estrogenic agents
11/06/2003WO2002002096A8 Oral compositions comprising host-response modulating agent
11/06/2003WO2001080633A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/06/2003US20030208080 Synthesis of epothilones, intermediates thereto and analogues thereof
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
11/06/2003US20030208041 Chloride channel polypeptides and nucleic acids, and their uses in obtaining compounds for preventing or treating a tick infestation
11/06/2003US20030207944 Aminotetralin derivative for the therapy of cardiovascular diseases
11/06/2003US20030207943 Administering dopamine, serotonin, and norepinephrine reuptake inhibitor (sibutramine) for treatment of neuropsychiatric disorders
11/06/2003US20030207936 Comprises fatty ester modified-polyoxyethylene glycol solubilizers
11/06/2003US20030207933 Compositions and methods for increasing the sensitivity of apoptosis-resistant tumor cells to inducers of apoptosis
11/06/2003US20030207932 Compositions that prevent post-traumatic hyperpigmentation and methods related thereto
11/06/2003US20030207930 Valsartan salts
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207917 1,4-di-substituted piperidines, some of which have M2 selectivity even higher than that of 3-alpha-chloroimperialine for treating cognitive disorders such as Alzheimer's disease
11/06/2003US20030207910 Treatment of HIV and AIDS
11/06/2003US20030207905 Method of treating pain using nalbuphine and opioid antagonists
11/06/2003US20030207904 Sensory nerve receptor agonist for topical delivery to the human lips, mouth, and to the anorectal area
11/06/2003US20030207903 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for sexual disfunction
11/06/2003US20030207897 Selective inhibitors of cyclooxygenase-2
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207891 Mixtures of adrenergic blocking agents, phosphodiesterase inhibitors, dopaminergic agents, vasoactive intestinal peptides and optionally carriers, in the form of tablets; time release agents; sexual disorders
11/06/2003US20030207888 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents
11/06/2003US20030207877 Pyridoquinoxaline antivirals
11/06/2003US20030207871 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
11/06/2003US20030207864 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
11/06/2003US20030207860 Neuropeptide Y Y5 receptor antagonists
11/06/2003US20030207859 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
11/06/2003US20030207852 Treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment.
11/06/2003US20030207851 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
11/06/2003US20030207848 Vitamin D analog and a retinoid wherein: (a) the vitamin D analog is capable of binding a vitamin D receptor or being converted in vivo into a compound capable of binding a vitamin D receptor; and (b) the retinoid is selected from the group; restoring the natural color of gray hair
11/06/2003US20030207846 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
11/06/2003US20030207845 Treating an inflammatory disease by administering a phosphodiesterase 4 inhibitor in combiantion with an inhibitor of prostaglandin synthesis, NSAIDs being exemplary.
11/06/2003US20030207844 Methods, compositions, and kits, are provided for the use of nitric oxide synthase inhibitors to prevent and reduce wrinkles.
11/06/2003US20030207843 Treating viral infections caused by retroviruses. In a particular aspect of the invention, there are provided methods for treating viral infections caused by retroviruses which have developed resistance to antivirals, such as, for
11/06/2003US20030207813 Retroviral protease inhibitor combinations
11/06/2003US20030207810 Method of treating malignancy associated hypercalcemia using active vitamin D analogues
11/06/2003US20030207794 Compounds which are alpha -halogenoacryloyl distamycin derivatives of formula (I) wherein R1 is a bromine or chlorine atom; R2 is a distamycin or distamycin-like framework as set forth in the specification; or a pharmaceutically acceptable
11/06/2003US20030207772 Warming and nonirritating lubricant compositions and method of comparing irritation
11/06/2003US20030207450 Derived from the neuroretina of the eye ex vivo and in vivo
11/06/2003US20030207447 Used to distinguish between arterial endothelial cells (arteries) and venous endothelial cells (veins)
11/06/2003US20030207435 Have increased anti-coagulation activity and resistance to inactivation by serpins
11/06/2003US20030207434 Phosphodiesterases
11/06/2003US20030207432 For refractory injuries, having human leukocyte elastase inhibitory activity
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207380 For diagnosis and treatment of estrogenic disorder of mutant ER alpha
11/06/2003US20030207347 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation
11/06/2003US20030207341 Methods for determining compounds capable of inhibiting the activities of the Ha-ras oncogene
11/06/2003US20030207330 Fibrinogen binding moieties
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207309 Diagnostics and therapeutics for macular degeneration-related disorders
11/06/2003US20030207301 Assay for the detection of factors that modulate the expression of INGAP
11/06/2003US20030207299 Involves nucleic acid and amino acid sequences of human kinases; used in the diagnosis, treatment, and prevention of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders
11/06/2003US20030207263 Method of screening therapeutic agents
11/06/2003US20030206972 Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect
11/06/2003US20030206970 Ophthalmic compositions containing galactomannan polymers and borate
11/06/2003US20030206969 Prenatal multivitamin/multimineral supplement
11/06/2003US20030206956 Topical treatment of prevention of ocular infections
11/06/2003US20030206954 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
11/06/2003US20030206951 At least three dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours.
11/06/2003US20030206941 Fast dissolving orally consumable films
11/06/2003US20030206924 Equine herpesvirus vaccine
11/06/2003US20030206923 Combination of soybean, mushroom and mung bean provides phytoestrogens, beta-glucans, saponins, inositol hexaphosphate, and lectins.
11/06/2003US20030206914 Synthetic antigens for CD1-restricted immune responses
11/06/2003US20030206911 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target
11/06/2003US20030206904 Method and therapeutic compositions for the treatment of myocardial infarction
11/06/2003US20030206900 Vectors derived from antibodies for transferring substances into cells
11/06/2003US20030206898 Use of anti-TNFalpha antibodies and another drug
11/06/2003US20030206889 Methods of treating anemia using recombinant adeno-associated virus virions
11/06/2003US20030206885 Vaccine immunotherapy for immune suppressed patients
11/06/2003US20030206874 Promoting whole body health
11/06/2003US20030206873 1,4-di(substituted phenyl)- derivatives; adapted for delayed release
11/06/2003US20030206869 Delivery of antidepressants through an inhalation route
11/06/2003US20030206866 1,2,3,6-Tetrahydropyrimidine-2-one compositions, articles and therapeutic methods for upper airway breathing disorders
11/06/2003US20030206861 Uses of diterpenoid triepoxides as an antiproliferative agent
11/06/2003DE20313224U1 Synergistic composition for treating metabolic syndrome, comprises swellable or gel-forming anorectic agent for inducing satiation and polymeric or other hypocholesterolemic and/or antidiabetic agent
11/06/2003CA2496454A1 Transdermal analgesic systems with reduced abuse potential
11/06/2003CA2484546A1 Methods and compositions for treatment of cancer pain
11/06/2003CA2484453A1 Medicinal compositions containing photocrosslinkable chitosan derivative
11/06/2003CA2484306A1 Prophylactic and therapeutic agent of diabetes mellitus
11/06/2003CA2484089A1 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
11/06/2003CA2483980A1 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands
11/06/2003CA2483635A1 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
11/06/2003CA2483557A1 Methods and compositions for treating, preventing or delaying onset of a neoplasm
11/06/2003CA2483551A1 Immunogenic agent therapy using plasmapheresis or exchange transfusion
11/06/2003CA2483449A1 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
11/06/2003CA2483340A1 Synergistic effects of nuclear transcription factor nf-.kappa.b inhibitors and anti-neoplastic agents
11/06/2003CA2483155A1 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
1 ... 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 ... 1151